 |
|
Evaluation of Bayesian Forecasting for Individualized Gentamicin Dosage in Infants Weighing 1000 g or Less
Kei Lui, MBBS, FRACP;
Scott M. Bryson, MSc Pharm;
Danica B. Irwin, BSc Pharm;
Simon Costello, MBBS, FRACP
Am J Dis Child. 1991;145(4):463-467.
Abstract
| |
• We evaluated the use of Bayesian forecasting for gentamicin therapy in outborn infants weighing 1000 g or less irrespective of postnatal age. Dosages were individualized using a computer program, guided by early serum gentamicin assays after a loading dose and a database of population kinetics. Steady-state gentamicin levels achieved were compared with those from a regimen based on guidelines. A total of 26 gentamicin courses were individualized in 19 infants of 22 to 33 weeks' gestation, weighing 500 to 1000 g at 1 to 41 days of age. All steady-state trough levels were between 1 and 2.4 mg/L; peak levels were between 4.4 and 9.3 mg/L. The 95% confidence intervals were in almost identical ranges. The prevalence of toxic and suboptimal trough levels was less when compared with that of 23 gentamicin courses based on guidelines in 17 control infants. We conclude that early individualized gentamicin dosage over a range of postnatal age is a practical alternative and serum level distributions appear superior.
(AJDC. 1991;145:463-467)
Author Affiliations
From the Departments of Pediatrics (Drs Lui and Costello) and Pharmacy (Mr Bryson and Ms Irwin), Hospital For Sick Children, Toronto, Ontario. Dr Lui is now with the Westmead Hospital, Westmead, New South Wales, Australia.
Footnotes
Accepted for publication September 27, 1990.
Reprint requests to Neonatal Intensive Care Unit, Department of Pediatrics, Westmead Hospital, Westmead, New South Wales, Australia 2145 (Dr Lui).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Once-daily Gentamicin Dosing in Newborn Infants
Lundergan et al.
Pediatrics 1999;103:1228-1234.
ABSTRACT
| FULL TEXT
|
